Mepsevii
Generic name: Vestronidase Alfa
Drug class:
Lysosomal enzymes
Usage of Mepsevii
Mepsevii contains an enzyme that occurs naturally in the body in healthy people. Some people lack this enzyme because of a genetic disorder. This medicine helps replace this missing enzyme in such people.
Mepsevii is used to treat some of the symptoms of a genetic condition called mucopolysaccharidosis VII (MYOO-koe-pol-ee-SAK-a-rye-DOE-sis Seven) or MPS VII, also called Sly syndrome.
MPS VII is a metabolic disorder in which the body lacks the enzyme needed to break down certain natural substances. These substances can build up in the body, causing enlarged organs, abnormal bone structure, changes in facial features, breathing problems, heart problems, vision or hearing loss, and changes in mental or physical abilities.
Mepsevii may improve walking ability in people with this condition. However, this medication is not a cure for MPS VII.
Mepsevii may also be used for purposes not listed in this medication guide.
Mepsevii side effects
Get emergency medical help if you have signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
An allergic reaction may occur during or shortly after infusion of Mepsevii. Tell your caregivers or get emergency medical help right away if you have any signs of a severe allergic reaction, such as:
Common side effects of Mepsevii may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Mepsevii
Tell your doctor if you have ever had:
Tell your doctor if you are pregnant or breastfeeding.
Relate drugs
- Agalsidase beta
- Aldurazyme
- Alglucerase
- Alglucosidase alfa
- Avalglucosidase alfa
- Avalglucosidase alfa-ngpt
- Myozyme
- Brineura
- Ceredase
- Cerezyme
- Cerliponase alfa
- Elaprase
- Elelyso
- Elfabrio
- Elosulfase alfa
- Fabrazyme
- Galsulfase
- Idursulfase
- Imiglucerase
- Kanuma
- Lamzede
- Laronidase
- Lumizyme
- Mepsevii
- Naglazyme
- Nexviazyme
- Olipudase alfa
- Olipudase alfa-rpcp
- Pegunigalsidase alfa-iwxj
- Pombiliti
- Sebelipase alfa
- Taliglucerase alfa
- Velaglucerase alfa
- Velmanase alfa-tycv
- Vestronidase alfa
- Vestronidase alfa-vjbk
- Vimizim
- VPRIV
- Xenpozyme
How to use Mepsevii
Mepsevii is given as an infusion into a vein. A healthcare provider will give you this injection.
Mepsevii is usually given once every 2 weeks. Mepsevii must be given slowly, and the infusion can take about 4 hours to complete.
About 30 to 60 minutes before each injection, you will be given other medications to help prevent a serious allergic reaction.
Tell your caregivers if you feel any burning, pain, or swelling around the IV needle when Mepsevii is injected.
You will be watched closely for at least 60 minutes after receiving Mepsevii, to make sure you do not have an allergic reaction.
Mepsevii doses are based on weight. Your dose needs may change if you gain or lose weight.
Warnings
An allergic reaction may occur during or shortly after infusion of this medicine. Tell your caregivers or get emergency medical help right away if you have any signs of a severe allergic reaction, such as sweating, trouble breathing, pale skin, blue lips or fingernails, and feeling like you might pass out.
What other drugs will affect Mepsevii
Other drugs may affect Mepsevii, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions